Imagine how frustrating it would be to not know whether you could physically sit through a dinner with friends or to worry about getting stuck in the grocery isle, fighting against a body that refuses to move. These nightmare-like experiences are what many Parkinson’s disease (PD) patients deal with on a daily basis. PD affects … Continue reading A step forward for Parkinson’s disease?
Month: December 2015
The Critical Role of Patient Advocates in Accelerating Stem Cell Cures
At CIRM, our goal is to bring stem cell therapies to patients with unmet medical needs, and we do that by funding the most promising and innovative research in regenerative medicine. A critical component of this goal is to support our patient advocates and make sure that their voices are heard. At this year’s World … Continue reading The Critical Role of Patient Advocates in Accelerating Stem Cell Cures
Why “Right to Try” laws are more feel good than do good
L to R: Don Gibbons, CIRM; Jeanne Loring; Beth Roxland; Aaron Levine In the last few years some 24 states have approved so-called “Right to Try” laws. These are intended to give terminally ill patients faster and easier access to experimental therapies. But a panel of experts at the World Stem Cell Summit in Atlanta … Continue reading Why “Right to Try” laws are more feel good than do good
To modify, or not to modify: Experts discuss human germline modification at WSCS15
The question of whether human germline modification, or the genetic modification of human reproductive cells, should be allowed or banned was discussed by a panel of experts in the Ethics, Law and Society session during Day 1 of the World Stem Cell Summit. On the panel were Aubrey de Grey, Chief Science Officer of the … Continue reading To modify, or not to modify: Experts discuss human germline modification at WSCS15
The bottom line: stem cell therapies will never be widely available if insurers won’t pay for them
The second session of the World Stem Cell Summit in Atlanta moved past all the promising science and right to the nitty-gritty of making cell-based therapies common. Four panelists reminded the audience that while they too are super excited by the potential for this field, unless folks developing therapies think about reimbursement early those therapies … Continue reading The bottom line: stem cell therapies will never be widely available if insurers won’t pay for them
Call to Action by FDA at World Stem Cell Summit
FDA Deputy Commissioner Dr. Robert Califf talking at the World Stem Cell Summit The World Stem Cell Summit annual conference in Atlanta kicked off today with a clarion call from Dr. Robert Califf, the Deputy Commissioner for the Food and Drug Administration. He told the audience: “We want you to accelerate translation to produce safe … Continue reading Call to Action by FDA at World Stem Cell Summit
Bringing down the gatekeeper for a stem cell-based Parkinson’s cure
On the surface, a stem cell-based cure for Parkinson’s disease seems pretty straight-forward. This age-related neurodegenerative disorder, which leads to progressively worsening tremors, slowness of movement and muscle rigidity, is caused by the death of a specific type of nerve cell, or neuron, that produces the chemical dopamine in a specific region of the brain. … Continue reading Bringing down the gatekeeper for a stem cell-based Parkinson’s cure
Using baking ingredient to create “nano” bombs and destroy cancer stem cells
"I am not a cook". Richard Nixon and the baking ingredient that could help win the "war on cancer" In 1971 President Richard Nixon declared a “war on cancer” and signed the National Cancer Act into law. Forty years later we’re still waging that war, and cancer is still one of the leading causes of … Continue reading Using baking ingredient to create “nano” bombs and destroy cancer stem cells
CIRM Scholar Spotlight: Berkeley’s Maroof Adil on stem cell transplants for Parkinson’s disease
Stem cell therapy has a lot of potential for Parkinson’s patients and the scientists that study it. One of our very own CIRM scholars, Maroof Adil, is making it his mission to develop stem cell based therapies to treat brain degenerating diseases like Parkinson’s. Maroof got his undergraduate degrees from MIT in both Chemical Engineering … Continue reading CIRM Scholar Spotlight: Berkeley’s Maroof Adil on stem cell transplants for Parkinson’s disease
Stem cell stories that caught our eye: growing better bone, synthetic diaphragms, nerves that make music
Here are some stem cell stories that caught our eye this past week. Some are groundbreaking science, others are of personal interest to us, and still others are just fun. A better way to grow bone. The term hydrogel gets tossed around a lot in tissue engineering discussions. The porous, generally pliable materials used to … Continue reading Stem cell stories that caught our eye: growing better bone, synthetic diaphragms, nerves that make music
The Stem Cellar 